D.E. Shaw & Co’s 1Life Healthcare ONEM Stock Holding History

D.E. Shaw & Co’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,797	Closed	-$264K	–	5169
2022 Q4	$264K	Sell	15,797 -66,149	-81%	-$1.12M	﹤0.01%	4142
2022 Q3	$1.41M	Sell	81,946 -357,554	-81%	-$5.61M	﹤0.01%	3324
2022 Q2	$3.45M	Buy	439,500 +285,596	+186%	+$2.45M	﹤0.01%	2575
2022 Q1	$1.71M	Buy	+153,904	New	+$1.72M	﹤0.01%	3461
2021 Q4	–	Sell	-36,902	Closed	-$716K	–	5836
2021 Q3	$747K	Sell	36,902 -41,837	-53%	-$1.08M	﹤0.01%	3816
2021 Q2	$2.6M	Buy	78,739 +14,550	+23%	+$549K	﹤0.01%	2667
2021 Q1	$2.51M	Buy	+64,189	New	+$3.01M	﹤0.01%	2396

D.E. Shaw & Co's ONEM Position: Q1 2023 in Review

D.E. Shaw & Co sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 15,797 shares — an estimated $264K sold.

D.E. Shaw & Co first reported a position in ONEM in Q1 2021 and held it in 7 quarters. The position peaked at $3.45M in Q2 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

D.E. Shaw & Co reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
D.E. Shaw & Co sold 15,797 1Life Healthcare shares in Q1 2023, an estimated $264K.
D.E. Shaw & Co first reported a position in 1Life Healthcare in Q1 2021 and held it in 7 quarters.
D.E. Shaw & Co's 1Life Healthcare position peaked at $3.45M in Q2 2022.
0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.